Cardiac Pacemakers and Implantable Cardiovascular-Defibrillators

  • Gerald A. SerwerEmail author
  • Ian H. Law


For 50 years, cardiac pacing has been the treatment for bradyarrhythmias for both adults and children. While this continues to be the main reason for permanent cardiac pacing, implantable devices to manage tachyarrhythmias have increased over the past decade. In addition, the use of resynchronization (biventricular) pacing has found a role to treat dyssynchronous cardiac function and congestive heart failure for all ages. This chapter reviews the current indications for cardiac pacing, particularly in reference to the treatment of tachyarrhythmias, current pacemaker technology, the variety of available devices and electrodes, implantation techniques, and chronic device and electrode testing and follow-up, particularly with relevance to optimal long-term management of the child who requires device implantation.


Bipolar electrodes Bipolar leads Bradyarrhythmias Cardiac resynchronization devices Device follow-up Dual-chamber pacemakers Endocardial leads Epicardial leads Heart failure Implantable cardio-defibrillators Pacemaker testing Single-chamber pacemakers Tachyarrhythmias Unipolar electrodes 

Suggested Reading

  1. Atallah J, Erickson CC, Cecchin F, Dubin AM, et al. Multi-institutional study of implantable defibrillator lead performance in children and young adults; results of the pediatric lead extractability and survival evaluation (PLEASE) study. Circulation. 2013;127:2393–402.CrossRefPubMedGoogle Scholar
  2. Aziz PF, Serwer GA, Bradley DJ, LaPage MJ, Romano-Hirsch JC, Bove EL, Ohye RG, Dick II M. Pattern of recovery of transient complete heart block following open heart surgery for congenital heart disease: duration alone predicts risk of late complete heart block. Pediatr Cardiol. 2013;34:99–1005.CrossRefGoogle Scholar
  3. Bauersfeld U, Schonbeck M, Candinas R, et al. Initial experiences with a new steroid-eluting bipolar epicardial pacing lead. Eur J Card Pacing Electro. 1996;6:222.Google Scholar
  4. Blom NA, et al. Transvenous biventricular pacing in a child after congenital heart surgery as an alternative therapy for congestive heart failure. J Cardiovas Electrophysiol. 2003;14(10):1110–2.CrossRefGoogle Scholar
  5. Cohen MI, Bush DM, Vetter VL, et al. Permanent epicardial pacing in pediatric patients. Circulation. 2001;103:2585–90.CrossRefPubMedGoogle Scholar
  6. Cohen MI, Buck K, Tanel RE, et al. Capture management efficacy in children and young adults with endocardial and unipolar epicardial systems. Europace. 2004;6:248–55.CrossRefPubMedGoogle Scholar
  7. Crossley GH, Chen J, Choucair W, et al. Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. J Am Coll Cardiol. 2009;54(22):2012–9.CrossRefPubMedGoogle Scholar
  8. Fischbach PS, Law IH, Dick II M, et al. Use of a single coil transvenous electrode with an abdominally placed implantable cardioverter defibrillator in children. Pacing Clin Electrophysiol. 2000;23:884.CrossRefPubMedGoogle Scholar
  9. Gregoratos G, Abrams J, Epstein AE, et al. Guideline update for implantation of pacemakers and antiarrhythmic devices: summary article. Circulation. 2002;106:2145–61.CrossRefPubMedGoogle Scholar
  10. Hwang C, Swerdlow CD, Kass RM, Gang ES, et al. Upper limit of vulnerability reliably predicts the defibrillation threshold in humans. Circulation. 1994;90:2308–14.CrossRefPubMedGoogle Scholar
  11. Janousek J, et al. Resynchronization pacing is a useful adjunct to the management of acute heart failure after surgery for congenital heart defects. Am J Cardiol. 2001;88(2):145–52.CrossRefPubMedGoogle Scholar
  12. Janoušek J, van Geldorp IE, Krupicková S, et al. Permanent cardiac pacing in children: choosing the optimal pacing site. A multicenter study. Circulation. 2013;127:613–23.CrossRefPubMedGoogle Scholar
  13. Johns JA, Fuh FA, Burger JD, Hammon Jr JW. Steroid-eluting epicardial pacing leads in pediatric patients: encouraging early results. J Am Coll Cardiol. 1992;20:395–401.CrossRefPubMedGoogle Scholar
  14. Karpawich PP, Horenstein MS, Webster P. Site specific right ventricular implant pacing to optimize paced left ventricular function in the young without and without congenital heart disease. Pacing Clin Electrophysiol. 2002;25:566.Google Scholar
  15. Kristensen L, Nielsen JC, Pedersen AK, et al. AV block and changes in pacing mode during long-term follow-up of 399 consecutive patients with sick sinus syndrome treated with an AAI/AAIR pacemaker. Pacing Clin Electrophysiol. 2001;24:358–65.CrossRefPubMedGoogle Scholar
  16. Lee JC, Shannon K, Boyle NG, et al. Evaluation of safety and efficacy of pacemaker and defibrillator implantation by axillary incision in pediatric patients. Pacing Clin Electrophysiol. 2004;27(3):304–7.CrossRefPubMedGoogle Scholar
  17. Rishi F, Hulse JE, Auld DO, et al. Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1997;29:734–40.CrossRefPubMedGoogle Scholar
  18. Ro PS, Chan DP, Ackley T, et al. Tissue doppler changes in pediatric complete heart block patients who are chronically paced. Congenit Heart Dis. 2009;4:448–53.CrossRefPubMedGoogle Scholar
  19. Serwer GA, Mericle JM, Armstrong BE. Epicardial ventricular pacemaker electrode longevity in children. Am J Cardiol. 1988;61:104–6.CrossRefPubMedGoogle Scholar
  20. Serwer GA, Uzark K, Dick II M. Endocardial pacing electrode longevity in children. J Am Coll Cardiol. 1990;15:212A.CrossRefGoogle Scholar
  21. Serwer GA, Dorostkar PC, LeRoy SS. Pediatric pacing and defibrillator usage. In: Kay GN, Wilkoff BL, Ellenbogen KA, editors. Clinical cardiac pacing and defibrillation. Philadelphia: W.B. Saunders; 2000.Google Scholar
  22. Stefanelli CB, Bradley DJ, Leroy S, et al. Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. J Interv Card Electrophysiol. 2002;6:235–44.CrossRefPubMedGoogle Scholar
  23. Stephenson EA, Casavant D, Tuzi J, et al.; on behalf of the ATTEST investigators. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol. 2003;92:871–6.Google Scholar
  24. Stephenson EA, Batra AS, Knilins TK, et al. A multicenter experience with novel implantable cardioverter-defibrillator configurations in the pediatric and congenital heart disease populations. J Cardiovasc Electrophysiol. 2006;17(1):41–6.CrossRefPubMedGoogle Scholar
  25. Strieper M, Karpawich P, Frias P, et al. Initial experience with cardiac resynchronization therapy for ventricular dysfunction in young patients with surgically operated congenital heart disease. Am J Cardiol. 2004;94:1352–4.CrossRefPubMedGoogle Scholar
  26. Walker F, et al. Long-term outcomes of cardiac pacing in adults with congenital heart disease. J Am Coll Cardiol. 2004;43(10):1894–901.CrossRefPubMedGoogle Scholar
  27. Weindling SN, Saul JP, Gamble WJ, et al. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol. 1998;82:525–7.CrossRefPubMedGoogle Scholar
  28. Zimmerman FJ, et al. Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery. Ann Thorac Surg. 2003;75(6):1775–80.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, New York 2015

Authors and Affiliations

  1. 1.Pediatric Cardiology, The University of Michigan Congenital Heart Center, Department of Pediatrics and Communicable DiseasesUniversity of MichiganAnn ArborUSA
  2. 2.Division of Cardiology, Department of PediatricsUniversity of Iowa Children’s Hospital, University of Iowa Carver College of MedicineIowa CityUSA

Personalised recommendations